Promoting low-flow anaesthesia and volatile anaesthetic agent choice

Louise A Carter, Molola Oyewole, Eleanor Bates, Kate Sherratt, Louise A Carter, Molola Oyewole, Eleanor Bates, Kate Sherratt

Abstract

Background: As doctors, we are increasingly aware of the financial implications of our practice. The need to work in a more conscientious, efficacious and cost-effective manner is greater than ever before. Environmental and financial benefits can be seen through employing the use of low-flow anaesthesia.

Aims: This quality improvement project aimed to make anaesthetic practice more environmentally friendly and to reduce departmental spending. This could be achieved by promoting the use of low-flow anaesthesia and by encouraging isoflurane use where appropriate.

Methods: All anaesthetic consultants and trainees were invited to fill out an initial questionnaire relating to their personal preferences and practices when conducting anaesthesia. There were specific questions relating to low-flow anaesthesia and isoflurane use. Our main measure of improvement was any decrease in the number of bottles of volatile agent ordered by the department from pharmacy. Monthly spot audits were conducted to assess gas flow rates and volatile agent use in theatre. Departmental spending figures relating to the purchase of volatile agent bottles were obtained from pharmacy. Information was then disseminated to anaesthetists on a monthly basis via a 'low-flow board', which showed pictorial and graphical representations of differing gas flows and volatile agent usage in relation to cost.

Results: Our project showed a trend for the increased use of low-flow anaesthesia within the department. We also showed a decrease in the number of bottles of volatile agent ordered: 18% fewer bottles ordered compared with the same period the previous year. This represented a 25% decrease in total departmental expenditure on volatile agents despite an increase in theatre activity.

Conclusion: Increasing awareness regarding anaesthetic choices and promoting low-flow anaesthesia and isoflurane use, translated into an overall decreased departmental spend on volatile agents without affecting patient care.

Keywords: anaesthesia; cost-effectiveness; healthcare quality improvement.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Graph showing the number of bottles of each volatile agent ordered per month. Note that there is a 1-month lag between the changes we implemented and an effect on bottles ordered. Our project started in September 2016; thus, results are relevant from October 2016.
Figure 2
Figure 2
Graph showing the percentage of theatres with FGF

References

    1. Foldes FF, Ceravolo AJ, Carpenter SL. The administration of nitrous oxide-oxygen anesthesia in closed systems. Ann Surg 1952;136:978–81. 10.1097/00000658-195212000-00009
    1. Baum J. Low flow anaesthesia. 2nd edn Butterworths, 2001.
    1. Virtue RW. Minimal-flow nitrous oxide anesthesia. Anesthesiology 1974;40:196–8. 10.1097/00000542-197402000-00021
    1. Nunn G. Low-Flow anaesthesia. Continuing Education in Anaesthesia Critical Care & Pain 2008;8:1–4. 10.1093/bjaceaccp/mkm052
    1. Yasny JS, White J. Environmental implications of anesthetic gases. Anesth Prog 2012;59:154–8. 10.2344/0003-3006-59.4.154
    1. Carbon Footprint from Anaesthetic gas use , 2013. Available:
    1. Sulbaek Andersen MP, Nielsen OJ, Wallington TJ, et al. . Medical intelligence article: assessing the impact on global climate from general anesthetic gases. Anesth Analg 2012;114:1081–5. 10.1213/ANE.0b013e31824d6150
    1. Kleemann PP. Humidity of anaesthetic gases with respect to low flow anaesthesia. Anaesth Intensive Care 1994;22:396–408. 10.1177/0310057X9402200414
    1. Aldrete JA, Cubillos P, Sherrill D. Humidity and temperature changes during low flow and closed system anaesthesia. Acta Anaesthesiol Scand 1981;25:312–4. 10.1111/j.1399-6576.1981.tb01657.x
    1. Chernin EL. Pharmacoeconomics of inhaled anesthetic agents: considerations for the pharmacist. Am J Health Syst Pharm 2004;61 Suppl 4(suppl_4):S18–S22. 10.1093/ajhp/61.suppl_4.S18

Source: PubMed

3
구독하다